History of pancreatic adenocarcinoma. ABDOMEN:LIVER, BILIARY TRACT: The liver is normal in morphology. There is a 1.7 x 1.4 cm focus adjacent to the gallbladder fossa which demonstrates signal dropout on out of phase imaging consistent with focal fatty infiltration. Additional 1.2 and 1.4 cm foci adjacent to the right portal vein demonstrates signal dropout on out of phase imaging consistent with focal fatty infiltration. No focal suspicious hepatic lesion, biliary ductal dilatation or vascular abnormality.SPLEEN: The spleen is normal in morphology without a discrete lesion. The splenic artery and vein are unremarkable.PANCREAS: Best appreciated on series 4 image 6 is a hypointense lesion in the pancreatic body measuring 2.1 x 1.8 cm which demonstrates heterogeneous enhancement on postcontrast imaging sequences and mild restricted diffusion. The distal pancreatic body and tail are mildly atrophic with decreased T1-weighted signal intensity.The lesion involves and nearly completely occludes the superior mesenteric vein (series 18 image 19 through 25). The lesion abuts the superior mesenteric artery (series 18 image 18). The lesion abuts the ventral aspect of the splenic vein (series 18 image 25) just proximal to the portal vein confluence.No suspicious peripancreatic or retroperitoneal lymphadenopathy.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Left renal subcentimeter cyst.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
2.1 cm pancreatic body mass with distal pancreatic parenchymal atrophy consistent with patient's stated history of pancreatic adenocarcinoma. Near complete occlusion of the superior mesenteric vein. Abutment of the superior mesenteric artery without frank encasement. No suspicious peripancreatic or retroperitoneal lymphadenopathy.